Search Companies Innoviva Inc. (INVA $19.57) $19.57 Cap: $1.27B View INVA Profile View Questions on INVA Detailed Quote Questions on this company? Become a Member Company Profile {tplLang.businessdescription | toLang tLang} { profileData.description } Read More {tplLang.details | toLang tLang} {tplLang.ceo | toLang tLang} {profileData.profile.details.ceo} {tplLang.employees | toLang tLang} {profileData.profile.details.employees | numeraljs '0,0'} {tplLang.issuetype | toLang tLang} {profileData.profile.details.issuetype | asIssueType} {tplLang.industryclassifications | toLang tLang} {tplLang.sector | toLang tLang} {profileData.profile.classification.sector} {tplLang.industry | toLang tLang} {profileData.profile.classification.industry} {tplLang.toolname| toLang tLang} There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}. Interactive Chart Key Ratios Earnings Analyst Recommendations 5i Recent Questions Innoviva Inc. (INVA $19.57) $19.57 Cap: $1.27B View INVA Profile View Questions on INVA Q: Innoviva has a low price to earnings of 6x times and plus 20 per cent roi in a growth industry and is funded by Glaxo. Can you explain the low valuation and is it a buy at these levels. Thank you Upvote 0 Read Answer Asked by Ian on April 14, 2021 Insiders Share Information SEC Filings News and Media
Innoviva Inc. (INVA $19.57) $19.57 Cap: $1.27B View INVA Profile View Questions on INVA Q: Innoviva has a low price to earnings of 6x times and plus 20 per cent roi in a growth industry and is funded by Glaxo. Can you explain the low valuation and is it a buy at these levels. Thank you Upvote 0 Read Answer Asked by Ian on April 14, 2021
